Early hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer-Reference-Cited by-同舟云学术

Early hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer

Published:2008-08 Issue:4 Volume:102 Page:442-445
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Langley Ruth E.,Godsland Ian F.,Kynaston Howard,Clarke Noel W.,Rosen Stuart D.,Morgan Rachel C.,Pollock Philip,Kockelbergh Roger,Lalani El-Nasir,Dearnaley David,Parmar Mahesh,Abel Paul D.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2008.07583.x/fullpdf

Reference19 articles.

1. Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy;Krupski;Cancer,2004

2. Proceedings: the Veterans Administration Cooperative Urological Research Group’s studies of cancer of the prostate;Byar;Cancer,1973

3. Estrogen therapy and liver function-metabolic effects of oral and parenteral administration;Von Schoultz;Prostate,1989

4. Transdermal estradiol therapy for advanced prostate cancer - forward to the past?;Ockrim;J Urol,2003

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens;Biomedicines;2024-07-23

2. A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design;Clinical Oncology;2024-01

3. Assessing the Mechanism of Action of “Fructus Ligustri Lucidi-Cuscutae Semen” in Prostate Cancer Treatment Using Network Pharmacology and Molecular Docking;Computational and Mathematical Methods in Medicine;2022-10-25

4. Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme;The Lancet;2021-02

5. Effects of estrogen receptor signaling on prostate cancer carcinogenesis;Translational Research;2020-08